Mecure H1 2025

from Green Ticker Tales · host Greentickertales

Mecure is one of the 5 listed players in the pharma space on the NGX. In fhis episode i discuss its H1 2025 earnings: Revenue split and pain points.

Episode metadata supplied by the publisher feed · Published Aug 16, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Mecure H1 2025

0:00 13:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 13 minutes long.

This episode was published on August 16, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!